Navigation Links
Smokers undergo the same changes in gene expression as patients with COPD
Date:5/9/2011

'Healthy' smokers experience changes in the gene expression of their lungs similar to that suffered by smokers who have developed Chronic Obstructive Pulmonary Disease (COPD). This is the conclusion of a new study, led by Catalan researchers, which confirms the crucial role that smoking plays in causing these alterations.

"Our objective was to analyse the expression of a range of genes in the pulmonary tissue samples of patients with COPD, whether smokers or not, and people who had undergone operations for cancer or lung transplants", Ricardo Bastos, lead author of the study and a researcher at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), tells SINC.

Using the real-time polymerase chain reaction (PCR) technique, the scientists analysed the expression of 42 genes related with processes such as tissue and vascular inflammation and change. Previous data already existed on the involvement of some of the proteins that code these genes in causing and developing the disease.

The authors then compared the expression profile of these genes between patients with moderate and severe COPD, 'healthy' smokers with normal lung function, and non-smokers. The main result of these studies was that the gene expression profile in the patients with moderate COPD was very similar to that of the 'healthy' smokers.

"The 'healthy' smokers experience similar gene expression changes as those seen in smokers who have developed the disease", concludes Bastos. "This once again underlines the decisive role of smoking in causing these changes".

In fact, these two groups have a more similar gene expression profile than patients with moderate and severe COPD. Previous laboratory studies have shown that the structural and cellular lung changes (to the airways and pulmonary arteries) of 'healthy' smokers are very similar to those in smokers with slight or moderate COPD.

The world's fourth leading cause of death

COPD is characterised by limited air flow, which is progressive and irreversible, caused by an abnormal inflammatory response in the lung, which at advanced stages can lead to the patient's death. All current treatments are merely symptomatic and palliative. Experts insist on the need to develop new therapies to help slow down the progression of the disease.

It is the most common respiratory disease caused by smoking which is the most important risk factor. It has high prevalence and mortality rates in industrialised and developing countries. Forecasts issued by the World Health Organisation (WHO) suggest that COPD will become the world's fourth leading cause of death (it is currently the sixth) by 2020.


'/>"/>

Contact: SINC
info@plataformasinc.es
0034-914-251-820
FECYT - Spanish Foundation for Science and Technology
Source:Eurekalert  

Related medicine news :

1. Brain imaging demonstrates that former smokers have greater willpower
2. For Nonsmokers, Healthy Living Cuts Death Rate in Half: Study
3. Many Smokers Still Deceived by Cigarette Labeling
4. Smokers believe silver, gold and slim cigarettes are less harmful
5. Blood Test Holds Hope for Spotting Lung Cancer in Nonsmokers
6. Babies Who Sleep in Smokers Rooms Face Thirdhand Smoke
7. Children of women who smoked during pregnancy at increased risk of becoming smokers
8. New targeted drug helps smokers stub it out
9. Prevalence of heavy smokers in US decreases
10. Text Messages May Help Smokers Kick the Addiction, Small Study Finds
11. Simple blood test detects early emphysema in smokers before symptoms appear
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Smokers undergo the same changes in gene expression as patients with COPD
(Date:1/20/2017)... ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 ... the lift is mounted on wheels, it can be wheeled out of the way and ... fasten to the deck. "We have transformed the feedback from customers into specific enhancements and ...
(Date:1/20/2017)... ... 20, 2017 , ... Source Vitál Apothecary, a skin and body care company ... the company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports ... work in the nutritional, sports and health industries a chance to meet in private ...
(Date:1/20/2017)... Florida (PRWEB) , ... January 20, 2017 , ... Lice ... head lice cases in families with school-aged children since the holiday season. , ... the holidays with their families, sharing hugs and taking photos, which is the head-to-head ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years of ... the clinical trial has been life-saving as she has been on the trial ... Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but a ...
(Date:1/20/2017)... ... 20, 2017 , ... “Mary Magdalene: Grace is Greater than Sin”: a ... witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation ... educator interacting with countless women who had little knowledge of the female characters portrayed ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... CLEVELAND , Jan. 19, 2017 ViewRay, ... (DFG), a federal institution supporting research in ... installation and patient treatments at the University Clinic Heidelberg ... The MRIdian Linac program will be headed ... who also heads radiation oncology at the German Cancer ...
(Date:1/19/2017)... , January 19, 2017 ... Option to Address Motor Symptoms and Motor Complications ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... , European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
Breaking Medicine Technology: